Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OptimizeRx Corp Director's Dealing 2014

May 22, 2014

33090_dirs_2014-05-22_21d8ebe2-d539-49b8-a533-41a62f07b88f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2014-05-01

Reporting Person: Lester David (Director, COO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-05-01 Common Stock A 50000 Acquired 423348 Direct

Footnotes

F1: The Issuer issued these shares to the Reporting Person under the 2013 Incentive Plan.